Cat. No. 1743
Alternative Name: Bay 11-7083
Chemical Name: (2E)-3-[[4-(1,1-Dimethylethyl)pheny
Biological ActivityIrreversible inhibitor of TNF-α-stimulated IκBα phosphorylation (IC50 ~ 10 μM); leads to decreased NF-κB and subsequent decreased expression of adhesion molecules. Also reversibly activates MAP kinases and stimulates apoptosis. Anti-inflammatory in vivo.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Safety Data Sheet
Pierce et al (1997) Novel inhibitors of cytokine-induced IkBa phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J.Biol.Chem. 272 21096. PMID: 9261113.
Hu et al (2001) An IκBα inhibitor causes leukemia cell death through a p38 MAP kinase-dependent, NF-κB-independent mechanism. Cancer Res. 61 6290. PMID: 11507084.
Scaife et al (2002) Nuclear factor κB inhibitors induce adhesion-dependent colon cancer apoptosis: implications for metastasis. Cancer Res. 62 6870. PMID: 12460901.
If you know of a relevant citation for this product please let us know.
View Related Products by Product Action
Keywords: Bay 11-7085, supplier, Irreversible, inhibitors, TNF-α, TNF-alpha-induced, IκB, IκBα, IkappaBalpha, phosphorylation, IkappaB, Nuclear, Factor, Kappa, B, NF-κB, NF-kappaB, NF-kB, Cytokine, Signaling, Signalling, Transcription, Factors, Bay11-7085, Bay117083, NF-κB and IκB Inhibitors
Find multiple products by catalog number
New Products in this Area
Stat3 inhibitor; blocks cancer stem cell self-renewalDMXAA
mSTING agonist; induces antitumor immunological responsesC 87
TNF-α inhibitorJTE 607 dihydrochloride
Cytokine release inhibitor; anti-inflammatory
December 15 - 17, 2015